Bristol-Myers Squibb Company News - October 23, 2026

Bristol Myers Shares Fall After Patient Death in Multiple Sclerosis Trial
BMY

Bristol Myers Shares Fall After Patient Death in Multiple Sclerosis Trial

Bristol Myers Squibb disclosed Friday that a patient died during a Phase 1 study of its experimental CAR-T cell therapy, zolacabtagene autoleucel (zola-cel),...
Bristol Myers Squibb Reports 59% Lower Progression Risk for Breast Cancer Drug
BMY

Bristol Myers Squibb Reports 59% Lower Progression Risk for Breast Cancer Drug

Bristol Myers Squibb and partner SystImmune announced positive results from the Phase 3 PANKU-Breast01 trial of experimental breast cancer drug izalontamab...